Applying ASCO GU 2024 Data to Clinical Practice in Bladder, RCC Care

Paul V. Viscuse, MD, spotlights key data from the 2024 Genitourinary Cancers Symposium in bladder cancer and renal cell carcinoma.

Related Keywords

United States ,San Francisco ,California ,Toni Choueiri ,Dorothy Byrne ,Paulv Viscuse ,Robert Motzer ,Nancy Kohlberg ,Harvard Medical School ,Genitourinary Tumors Multidisciplinary Clinic Center ,Memorial Sloan Kettering Cancer Center ,International Metastatic Renal Cell Carcinoma Database Consortium ,Lank Center ,Cancer Research Of The National Institute ,Genitourinary Oncology Service ,Genitourinary Oncology At Dana Farber Cancer Institute ,University Of Virginia ,National Clinical Trials Network ,Cancers Symposium ,Andrea Apolo ,Bladder Cancer Section ,Genitourinary Malignancies Branch ,Bladder Cancer ,Cancer Research ,National Cancer Institute ,Kidney Cancer ,Dorothy Byrne Chair ,Clinical Oncology ,Genitourinary Oncology ,Dana Farber Cancer Institute ,Kidney Cancer Program ,Harvard Cancer Center ,Nancy Kohlberg Chair ,Cancer Statistics ,Health Organization Classification ,Urinary System ,Urinary Tract ,Practice Guidelines ,